查詢結果分析
相關文獻
- 初次化療婦癌患者於治療期間經歷之副作用變化狀況的探討
- 藥物代謝、交互作用與副作用
- 選擇性血清素再吸收抑制劑
- Immunogenicity and Reactogenicity of Two Recombinant Hepatitis B Vaccines in Healthy Adolescents on Two-dose Schedule
- Effect of Local Massage on Vaccination: DTP and DTPa
- 飼料添加物(劑)的使用及意外副作用
- 飼料添加物(劑)的使用及意外副作用
- 對於藥物副作用(臨床安全性)報告的看法
- Warfarin 之副作用
- 攝護腺癌之傳統放射線治療--長庚紀念醫院十四年之經驗
第1筆 /總和 1 筆
/ 1 筆
頁籤選單縮合
題 名 | 初次化療婦癌患者於治療期間經歷之副作用變化狀況的探討=The Study of Side Effects During the Period of Treatment with Gynecological Cancer Patients for Initial Chemotherapy |
---|---|
作 者 | 張瑛瑛; 劉雪娥; 張廷彰; 楊志堅; | 書刊名 | 腫瘤護理雜誌 |
卷 期 | 2:1 2002.06[民91.06] |
頁 次 | 頁29-43 |
分類號 | 419.77 |
關鍵詞 | 初次化療; 婦癌患者; 副作用; Initial chemotherapy; Side effects; Gynecological cancer patients; |
語 文 | 中文(Chinese) |
中文摘要 | 本研究目的在探討初次靜脈化療之婦癌患者副作用狀況。採時間序列性研究設計,以立意取樣的方式,選擇初次接受三個住院化療療程之婦癌患者為研究對象,自民國89年10月至民國90年5月共收得有效樣本23位。結果顯示三次化學治療療程期間的副作用頻率以疲倦、掉頭髮、噁心嘔吐、食慾不振、味覺改變及失眠最多。副作用嚴重度方面則以掉頭髮、失眠、食慾不振、發燒/白血球降低及便秘較高。三次化學治療期間,各副作用的發生頻率並無顯著差異。但是第一個療程副作用的嚴重度顯著大於第三個療程(p=0.039),第三個療程中,接受VIP療程者的副作用頻率(Mean=9.75)顯著多於Cisplantin加其他藥物之療程者(Mean=6.08)(p<.05)。研究結果可提供護理人員,照顧及指導初次化療之婦癌患者副作用及其自我照顧的參考。 |
英文摘要 | The purposes of this study were to explore the side effects for Gynecological cancer patients who received the initial chemotherapy. Time-series research design was adopted as guide for this study. Purpose sampling was used to select subjects who met inclusion criteria. A total of 23 patients were selected from October 2000 to May 2001. The-missing rate was 18%. The results indicated: The highest occurrence of side effects in three courses of chemotherapy was: fatigue, alopecia, nausea/vomiting, decreased appetite, taste changes, and sleeping difficulty. The most severe side effect was stated as follow: alopecia, sleeping difficulty, decreased appetite, fever/neutropenia, and constipation. The occurrence of side effects was no significant in three courses of chemotherapy. The severeness of the side effects in the first-therapy was higher than third-therapy (p=0.039). The frequency of side effects of VIP regimen (Mean=9.75) was more than Cisplantin adding other chemotherapy medicines (Mean=6.08) (p<.05) in the third-therapy. These findings provide guidance to providers the health care providers to promote quality of care by educating self-care activities for these Gynecological cancer patients who received their initial chemotherapy. |
本系統中英文摘要資訊取自各篇刊載內容。